Prof. In-Geol Choi receives the 2018 QUIGEN sponsorship for next generation sequencing
He was the only Asian scholar among the five awardees, each receiving a USD 20,000 sponsorship.
▲ Prof. In-Geol Choi (left) from Korea University was given the award at the reward and recognition ceremony hosted by QIAGEN Korea at Millennium Seoul Hilton Hotel on November 22.
Prof. In-Geol Choi from the Department of Biotechnology, College of Life Sciences and Biotechnology, received a USD 20,000 sponsorship of QIAGEN for his next-generation sequencing (NGS) research.
The NGS Sponsorship program of QIAGEN selects five NGS researchers from Asia, Europe and the USA based on their applications and offers each a USD 20,000 sponsorship.
Prof. Choi was the only Asian awardee of the 2018 QIAGEN sponsorship round. Of his fellow recipients, two were from the USA (Dr. Sara Cooper from the HudsonAlpha Institute for Biotechnology, Dr. Monali Manohar from Stanford University) and two from Europe (Dr. Alice Giustacchini from University College London, Dr. Manching Ku from University of Freiburg).
Prof. Choi is leading the Computational & Synthetic Biology Laboratory at Korea University that conducts NGS and analyzes the genetic code of all living things through sequencing and annotating the genomes, transcriptomes and microbiomes of bacteria, fungi, insects and humans.
Headquartered in the Netherlands, QIAGEN is a world leading biotechnology company with over 500 products, 2,000 patents and licenses, 35 branch offices across the globe and over 5,000 employees. The QGEN-listed company has generated annual revenues of some USD 1.5 billion and reached a market capitalization of approximately USD 9 billion. Recently, it has aggressively invested in developing NGS solutions.